Andrew A. Carmen

2.3k total citations · 1 hit paper
15 papers, 1.9k citations indexed

About

Andrew A. Carmen is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Andrew A. Carmen has authored 15 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Andrew A. Carmen's work include Histone Deacetylase Inhibitors Research (5 papers), Genomics and Chromatin Dynamics (5 papers) and Fungal and yeast genetics research (4 papers). Andrew A. Carmen is often cited by papers focused on Histone Deacetylase Inhibitors Research (5 papers), Genomics and Chromatin Dynamics (5 papers) and Fungal and yeast genetics research (4 papers). Andrew A. Carmen collaborates with scholars based in United States, United Kingdom and Switzerland. Andrew A. Carmen's co-authors include Stephen E. Rundlett, Michael Grunstein, Noriyuki Suka, Bryan M. Turner, Michael Grunstein, Ryûji Kobayashi, S.G. Bavykin, Jian Wu, Lisa Milne and Anton Bittner and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Andrew A. Carmen

15 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes that regulate silencing and transcription

1996 530 citations Stephen E. Rundlett, Andrew A. Carmen et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Andrew A. Carmen

Since Specialization

Citations

This map shows the geographic impact of Andrew A. Carmen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew A. Carmen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew A. Carmen more than expected).

Fields of papers citing papers by Andrew A. Carmen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew A. Carmen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew A. Carmen. The network helps show where Andrew A. Carmen may publish in the future.

Co-authorship network of co-authors of Andrew A. Carmen

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew A. Carmen. A scholar is included among the top collaborators of Andrew A. Carmen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew A. Carmen. Andrew A. Carmen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	65 Effect of oviductal fluid extracellular vesicle supplementation during in vitro culture on development and quality of bovine embryos 2019 ·Reproduction Fertility and Development ·Daniel Le Bourhis, (unknown), Pascal Mermillod, Andrew A. Carmen, Pascal Salvetti, (unknown)	1
2	Genome-Wide Analysis of Mouse Myeloma Cell Lines Expressing Therapeutic Antibodies 2007 ·Biotechnology Progress ·Haimanti Dorai, Katherine Li, Chaohao Huang, Anton Bittner, Jose Galindo, Andrew A. Carmen	5
3	Genome-Wide Analysis of Mouse Myeloma Cell Lines Expressing Therapeutic Antibodies 2007 ·Biotechnology Progress ·Haimanti Dorai, Katherine Li, Chaohao Huang, Anton Bittner, Jose Galindo, Andrew A. Carmen	4
4	Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity 2006 ·Molecular Carcinogenesis ·Alex Nie, Michael McMillian, J. Brandon Parker, Angelique M. Leone, Stewart Bryant, Lynn Yieh, Anton Bittner, (unknown), Andrew A. Carmen, Jackson Wan, Peter G. Lord	123
5	Acetylation of the Yeast Histone H4 N Terminus Regulates Its Binding to Heterochromatin Protein SIR3 2002 ·Journal of Biological Chemistry ·Andrew A. Carmen, Lisa Milne, Michael Grunstein	171
6	Gene-expression-based responses to drug treatment 2002 ·Drug News & Perspectives ·Marianne D. De Backer, Robin L. Thurmond, Andrew A. Carmen, Walter Luyten	5
7	Highly Specific Antibodies Determine Histone Acetylation Site Usage in Yeast Heterochromatin and Euchromatin 2001 ·Molecular Cell ·Noriyuki Suka, (unknown), Andrew A. Carmen, Jian Wu, Michael Grunstein	370
8	HDA2 and HDA3 are related proteins that interact with and are essential for the activity of the yeast histone deacetylase HDA1 2001 ·Proceedings of the National Academy of Sciences ·Jian Wu, Andrew A. Carmen, Ryûji Kobayashi, Noriyuki Suka, Michael Grunstein	44
9	Yeast HOS3 forms a novel trichostatin A-insensitive homodimer with intrinsic histone deacetylase activity 1999 ·Proceedings of the National Academy of Sciences ·Andrew A. Carmen, Patrick R. Griffin, Jimmy Calaycay, Stephen E. Rundlett, (unknown), Michael Grunstein	70
10	Transcriptional repression by UME6 involves deacetylation of lysine 5 of histone H4 by RPD3 1998 ·Nature ·Stephen E. Rundlett, Andrew A. Carmen, Noriyuki Suka, Bryan M. Turner, Michael Grunstein	374
11	The Regulation of Gene Activity by Histones and the Histone Deacetylase RPD3 1998 ·Cold Spring Harbor Symposia on Quantitative Biology ·Noriyuki Suka, Andrew A. Carmen, Stephen E. Rundlett, Michael Grunstein	26
12	HDA1 and HDA3 Are Components of a Yeast Histone Deacetylase (HDA) Complex 1996 ·Journal of Biological Chemistry ·Andrew A. Carmen, Stephen E. Rundlett, Michael Grunstein	166
13	HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes that regulate silencing and transcription breakdown → 1996 ·Proceedings of the National Academy of Sciences ·Stephen E. Rundlett, Andrew A. Carmen, Ryûji Kobayashi, S.G. Bavykin, Bryan M. Turner, Michael Grunstein	530
14	Transcriptional regulation by an upstream repression sequence from the yeast enolase gene ENO1 1995 ·Yeast ·Andrew A. Carmen, Paul K. Brindle, (unknown), Michael J. Holland	9
15	The upstream repression sequence from the yeast enolase gene ENO1 is a complex regulatory element that binds multiple trans-acting factors including REB1 1994 ·Journal of Biological Chemistry ·Andrew A. Carmen, Michael J. Holland	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact